Revenue breakdown: Technology (39.3%), Recurring Technology (39.2%), Professional Services (21.5%).
8-K
Health Catalyst, Inc. entered into a transition agreement with former CEO Daniel Burton, appointing him as Strategic Advisor until December 31, 2026, following his retirement effective February 12, 2026.